SCHEMBL5507559

SCHEMBL5507559

NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
GSTK1 Q9Y2Q3 1/20 0.40
ECE1 P42892 4/20 0.36
GLO1 Q04760 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP8 P22894 2/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA3 P42263 1/20 0.33
ITGB3 P05106 3/20 0.32
ITGB1 P05556 3/20 0.32
ITGAV P06756 3/20 0.32
ITGA5 P08648 3/20 0.32
MDM4 O15151 2/20 0.32
PTPN1 P18031 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9180258 1.00 PTGS1 (0.40) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL9096940 0.99 PTGS1 (0.39) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL8448660 0.97 PTGS1 (0.42) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL3493292 0.97 PTGS1 (0.42) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL7571502 0.97 PTGS1 (0.42) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL1472099 0.97 PTGS1 (0.42) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL6136563 0.97 PTGS1 (0.42) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL8434776 0.96 PTGS1 (0.39) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL8046861 0.96 PTGS1 (0.39) PTGS1GSTK1ECE1GLO1MEN1
SCHEMBL8722673 0.96 PTGS1 (0.39) PTGS1GSTK1ECE1GLO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042953-A1 ANTIBODY-DRUG COMPLEXES WITH TOPOISOMERASE INHIBITORS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-02-27 WO claimed
EP-1210442-A4 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS CHEIL JEDANG CORP (KR) 2005-10-26 EP claimed
EP-1210442-A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS Cheil Jedang Corporation (KR) 2002-06-05 EP claimed
WO-2000061769-A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS CHEIL JEDANG CORPORATION (KR) 2000-10-19 WO claimed
WO-2025042953-A1 ANTIBODY-DRUG COMPLEXES WITH TOPOISOMERASE INHIBITORS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-02-27 WO disclosed
CN-110139666-B Polypeptides having lysozyme activity, polynucleotides encoding same, uses and compositions thereof 诺维信公司 2024-07-05 CN disclosed
CN-114085850-B Cloning of aromatic phenol amine synthetic gene cluster in rice and application in disease resistance 海南大学 2024-01-26 CN disclosed
CN-117321197-A Background-dependent, double-stranded DNA-specific deaminase and uses thereof 马奇疗法公司 2023-12-29 CN disclosed
CN-117083381-A Compositions and methods for targeting inflammatory cells or activating cells and treating or ameliorating inflammatory disorders and pain 加州大学董事会 2023-11-17 CN disclosed
CN-115335530-A Submerged fermentation method 诺维信公司 2022-11-11 CN disclosed
CN-109310740-B Composition for preventing or treating sarcopenia using SLIT-ROBO system 株式会社大熊制药 2022-10-14 CN disclosed
CN-115011417-A Detergent compositions comprising bacterial mannanase AB酶股份有限公司 2022-09-06 CN disclosed
US-6005088-A GENE USEFUL AS AN INDICATOR IN THE PROPHYLAXIS, DIAGNOSIS AND TREATMENT OF DISEASES IN HUMANS SUCH AS CANCER AND HEREDITARY DISEASES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-12-21 US disclosed
EP-0842270-A4 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI FOR DIAGNOSTICS AND THERAPEUTICS ASTRA AB (SE) 1999-02-24 EP disclosed
CN-1186516-A Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics ASTRA AB (SE) 1998-07-01 CN disclosed
WO-1998021367-A1 GENETIC TEST FOR EQUINE SEVERE COMBINED IMMUNODEFICIENCY DISEASE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-05-22 WO disclosed
EP-0842270-A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI FOR DIAGNOSTICS AND THERAPEUTICS AKTIEBOLAGET ASTRA (SE) 1998-05-20 EP disclosed
EP-0796332-A1 NEISSERIA MENINGITIDIS SUBUNIT TBP2 PASTEUR MERIEUX SERUMS ET VACCINS, Société Anonyme : (FR) 1997-09-24 EP disclosed
WO-1997013860-A1 NEISSERIA MENINGITIDIS SUBUNIT TBP2 PASTEUR MERIEUX SERUMS & VACCINS (FR) 1997-04-17 WO disclosed
WO-1996040893-A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO HELICOBACTER PYLORI FOR DIAGNOSTICS AND THERAPEUTICS ASTRA AKTIEBOLAG (SE) 1996-12-19 WO disclosed